What are the clinical uses of doxycycline?

Clinical Uses of Doxycycline

Doxycycline is a broad-spectrum tetracycline antibiotic with extensive clinical applications spanning infectious disease treatment, prophylaxis, and anti-inflammatory therapy, with the most recent 2024 CDC guidelines establishing its novel use as postexposure prophylaxis for bacterial STIs in high-risk populations.

FDA-Approved Treatment Indications

Doxycycline is FDA-approved for treating a wide range of bacterial infections 1:

Rickettsial Infections

• Rocky Mountain spotted fever
• Typhus fever and typhus group
• Q fever
• Rickettsialpox
• Tick fevers

Sexually Transmitted Infections

• Chlamydia trachomatis infections (recommended first-line treatment) 2, 3
  • Uncomplicated urethral, endocervical, or rectal infections
  • Lymphogranuloma venereum
  • Trachoma
  • Inclusion conjunctivitis
• Syphilis (alternative treatment in nonpregnant patients with severe penicillin allergy or when penicillin unavailable) 2
• Nongonococcal urethritis (Ureaplasma urealyticum)
• Uncomplicated gonorrhea (when penicillin contraindicated, though resistance is increasing) 2

Respiratory Infections

• Mycoplasma pneumoniae
• Streptococcus pneumoniae (upper respiratory infections)
• Haemophilus influenzae
• Klebsiella species
• Psittacosis (Chlamydia psittaci)

Other Bacterial Infections

• Anthrax (including inhalational anthrax post-exposure)
• Plague (Yersinia pestis)
• Tularemia (Francisella tularensis)
• Cholera (Vibrio cholerae)
• Brucellosis (with streptomycin)
• Lyme disease (Borrelia recurrentis)
• Chancroid (Haemophilus ducreyi)
• Granuloma inguinale

Adjunctive Therapy

• Acute intestinal amebiasis (adjunct to amebicides) 1
• Severe acne 1

Prophylaxis Indications

Malaria Prevention

FDA-approved for prophylaxis of Plasmodium falciparum malaria in short-term travelers (<4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains 1.

Novel STI Prevention (2024 CDC Guidelines)

The CDC now recommends doxycycline postexposure prophylaxis (doxyPEP) for MSM and transgender women who have had a bacterial STI diagnosed in the past 12 months 2.

Specific DoxyPEP Protocol:

• Dose: 200 mg taken within 72 hours after oral, vaginal, or anal sex
• Maximum frequency: Not to exceed 200 mg every 24 hours
• Efficacy: Reduces syphilis and chlamydia by >70%, gonorrhea by ~50% 2
• Target population: MSM and transgender women with recent bacterial STI (syphilis, chlamydia, or gonorrhea) in past 12 months 2

Implementation Requirements:

DoxyPEP must be provided within comprehensive sexual health approach 2:

• Risk reduction counseling
• STI screening at anatomic sites of exposure every 3-6 months
• HIV screening per current recommendations
• Reassessment of ongoing need every 3-6 months
• Linkage to HIV PrEP or care as appropriate

Important caveat: DoxyPEP has NOT shown benefit in cisgender women, likely due to adherence issues 4. Current recommendations are specific to MSM and transgender women only.

Anti-Inflammatory and Non-Antibiotic Uses

Beyond antimicrobial activity, doxycycline has significant anti-inflammatory properties 5, 6:

Dermatologic Conditions

• Rosacea (at sub-antimicrobial doses)
• Acne vulgaris (both antimicrobial and anti-inflammatory effects)
• Bullous dermatoses
• Neutrophilic diseases
• Pyoderma gangrenosum
• Sarcoidosis 6

Mechanism of Anti-Inflammatory Action

Doxycycline inhibits matrix metalloproteinases (MMPs), affecting 6:

• Proteolysis
• Angiogenesis
• Apoptosis
• Vascular endothelial function
• Extracellular matrix degradation

Pharmacologic Advantages

Doxycycline has several properties making it clinically favorable 7, 8:

• Excellent oral absorption (90-100%, minimally affected by food)
• Long half-life (~12 hours) allowing once or twice daily dosing 2
• Superior tissue penetration into kidney, lung, prostate, reproductive tissues, sinus secretions
• No renal dose adjustment required (does not accumulate in renal insufficiency) 7
• Not removed by hemodialysis 7

Common Adverse Effects and Mitigation

Most common side effects 2:

• Photosensitivity (counsel on sun protection)
• Gastrointestinal symptoms (nausea, vomiting, diarrhea)
• Esophageal erosion/ulceration

Risk Mitigation Strategies 2:

• Take with full glass of liquid on full stomach
• Avoid lying down for 1 hour after administration
• Separate from dairy products, antacids, calcium, iron, magnesium, or sodium bicarbonate by at least 2 hours

Clinical Considerations

Contraindications: Pregnancy (all tetracyclines), children <8 years (tooth discoloration), severe hepatic dysfunction.

Resistance concerns: While doxycycline remains effective against many N. gonorrhoeae strains, elevated antimicrobial resistance exists 2. Culture and susceptibility testing recommended for certain infections 1. The long-term impact of widespread doxyPEP use on resistance patterns, particularly for gonorrhea and off-target bacteria, requires ongoing surveillance 4.

Drug interactions: Review all medications including over-the-counter products; no clinically relevant interactions with gender-affirming hormonal therapy 2.